Skip to main content

Research Repository

Advanced Search

Outputs (12)

Screening for thyroid disease in patients with type 2 diabetes mellitus: An evaluation of current practice (2019)
Journal Article
Heald, A. H., Palit, T., Livingston, M., Duff, C., & Fryer, A. (2019). Screening for thyroid disease in patients with type 2 diabetes mellitus: An evaluation of current practice. International Journal of Clinical Practice, https://doi.org/10.1111/IJCP.13302

The above article from International Journal of Clinical Practice, published online on 7th December 2018 in Wiley Online Library (http://wileyonlinelibrary.com) has been withdrawn by agreement between the authors, the journal Editor in Chief, Leslie... Read More about Screening for thyroid disease in patients with type 2 diabetes mellitus: An evaluation of current practice.

SAT-371 Correlation of Midnight and Post Dexamethasone Salivary Cortisone and Cortisol with Post Dexamethasone Serum Cortisol Concentrations In Patients with Unilateral and Bilateral Adrenal Incidentalomas (2019)
Presentation / Conference Contribution
Naseem, A., Mason, O., Ensah, G., Keevil, B., Hanna, F., Fryer, A., & Issa, B. SAT-371 Correlation of Midnight and Post Dexamethasone Salivary Cortisone and Cortisol with Post Dexamethasone Serum Cortisol Concentrations In Patients with Unilateral and Bilateral Adrenal Incidentalomas. Presented at 101st Annual Meeting of the Endocrine Society; March 23 – 26th, 2019, New Orleans, Louisiana, USA

Correlation between midnight and post dexamethasone salivary cortisone and cortisol and post dexamethasone serum cortisol concentrations in patients with unilateral and bilateral adrenal incidentalomas Background: The commonest functional abnormality... Read More about SAT-371 Correlation of Midnight and Post Dexamethasone Salivary Cortisone and Cortisol with Post Dexamethasone Serum Cortisol Concentrations In Patients with Unilateral and Bilateral Adrenal Incidentalomas.

SAT-374 Adrenal Incidentaloma Management: Development of a Cost-Effectiveness Tool (2019)
Presentation / Conference Contribution
Hanna, F. W. F., Issa, B., Lea, S., George, C., Golash, A., Firn, M., Sim, J., Xydopoulos, G., Fordham, R., & Fryer, A. SAT-374 Adrenal Incidentaloma Management: Development of a Cost-Effectiveness Tool. Presented at ENDO 2019 - 101st Annual Meeting of the Endocrine Society (23-26 March 2019), New Orleans, Louisiana, USA

SAT-372 Correlation of Serum Dexamethasone and Cortisol Concentrations Post Dexamethasone 1 Mg in the Overnight Dexamethasone Suppression Test in Patients with Unilateral and Bilateral Adrenal Incidentalomas (2019)
Presentation / Conference Contribution
Naseem, A., Mason, O., Ensah, G., Keevil, B., Hanna, F. W. F., Fryer, A., & Issa, B. SAT-372 Correlation of Serum Dexamethasone and Cortisol Concentrations Post Dexamethasone 1 Mg in the Overnight Dexamethasone Suppression Test in Patients with Unilateral and Bilateral Adrenal Incidentalomas. Presented at ENDO 2019 Abstracts - 101st Annual Meeting of the Endocrine Society; March 23 – 26th, 2019, New Orleans, Louisiana, USA

Background: The most common functional abnormality in adrenal incidentalomas (AI) is autonomous cortisol secretion. Most guidelines recommend a 1 mg overnight dexamethasone suppression test (ONDST) as a screening test for this abnormality. There is s... Read More about SAT-372 Correlation of Serum Dexamethasone and Cortisol Concentrations Post Dexamethasone 1 Mg in the Overnight Dexamethasone Suppression Test in Patients with Unilateral and Bilateral Adrenal Incidentalomas.

More frequent lithium testing associates with lower hospital admission rate for bipolar disorder - what this tells us about GP practice engagement with this group (2019)
Presentation / Conference
Holland, D., Healy, A., Stedman, M., Duff, C., Fryer, A., Yung, A., & Bailey, S. (2019, April). More frequent lithium testing associates with lower hospital admission rate for bipolar disorder - what this tells us about GP practice engagement with this group. Presented at 27th European Congress of Psychiatry, Warsaw, Poland

Background and aims.– Lithium treatment is a cornerstone of bipolar
affective disorder management.
We determined how frequency of lithium level checks at GP (family) practice level relates to psychiatric admission rate for bipolar
affective disord... Read More about More frequent lithium testing associates with lower hospital admission rate for bipolar disorder - what this tells us about GP practice engagement with this group.

More frequent lithium testing in UK Primary Care associates with a lower hospital admission rate for bipolar disorder-What this can tell us about GP practice engagement with this group. (2019)
Journal Article
Holland, D., Duff, C. J., Farman, S., Fryer, A. A., Yung, A., Bailey, S., & Heald, A. H. (2019). More frequent lithium testing in UK Primary Care associates with a lower hospital admission rate for bipolar disorder-What this can tell us about GP practice engagement with this group. International Journal of Clinical Practice, 73(4), e13277. https://doi.org/10.1111/ijcp.13277